NEFL and myeloid sarcoma: In contrast to Neurofilament Light Chain (NFL), a promising biomarker for neurodegeneration increasingly used in MS whose serum levels correlate well with CSF levels, it is unclear whether BDNF levels in serum reflect those in CSF (57).